SPXL:ARCA-Direxion Daily S&P 500 Bull 3X Shares (USD)

ETF | Trading--Leveraged Equity | NYSE Arca

Last Closing

USD 137.93

Change

-8.87 (-6.04)%

Market Cap

USD 0.55B

Volume

7.07M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

The investment seeks daily investment results, before fees and expenses, of 300% of the performance of the S&P 500? Index. The fund, under normal circumstances, creates long positions by investing at least 80% of its assets in the securities that comprise the S&P 500? Index and/or financial instruments that provide leveraged and unleveraged exposure to the index. These financial instruments include: swap agreements; futures contracts; options; reverse repurchase agreements; exchange-traded funds ("ETFs"); and other financial instruments. The index is a capitalization-weighted index composed of 500 common stocks. The fund is non-diversified.

Inception Date: 05/11/2008

Primary Benchmark: S&P 500 TR USD

Primary Index: S&P 500 TR USD

Gross Expense Ratio: 0.97%

Management Expense Ratio: 1.00 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-28 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Mer Price(Change) Market Cap
SOXL Direxion Daily Semiconductor B.. 1.10 %

N/A

USD 8.29B
QLD ProShares Ultra QQQ 0.95 %

N/A

USD 6.07B
FNGU MicroSectors FANG+ Index 3X Le.. 0.00 %

N/A

USD 5.57B
SSO ProShares Ultra S&P500 0.90 %

N/A

USD 4.37B
UPRO ProShares UltraPro S&P500 0.92 %

N/A

USD 3.08B
TECL Direxion Daily Technology Bull.. 1.17 %

N/A

USD 2.48B
YINN Direxion Daily FTSE China Bull.. 1.02 %

N/A

USD 1.91B
USD ProShares Ultra Semiconductors 0.95 %

N/A

USD 0.82B
LABU Direxion Daily S&P Biotech Bul.. 1.14 %

N/A

USD 0.66B
UDOW ProShares UltraPro Dow30 0.95 %

N/A

USD 0.59B

ETFs Containing SPXL

DRAI Draco Evolution AI ETF 5.12 % 0.00 %

N/A

USD 0.01B
GTAA 0.00 % 1.25 %

N/A

N/A
LGH HCM Defender 500 Index ET.. 0.00 % 0.00 %

N/A

USD 0.46B

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -18.24% 30% F 11% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -18.24% 30% F 10% F
Trailing 12 Months  
Capital Gain 2.91% 60% D- 61% D-
Dividend Return 0.40% 21% F 5% F
Total Return 3.31% 58% F 48% F
Trailing 5 Years  
Capital Gain 453.94% 90% A- 95% A
Dividend Return 9.89% 65% D 20% F
Total Return 463.82% 90% A- 95% A
Average Annual (5 Year Horizon)  
Capital Gain 39.09% 68% D+ 92% A
Dividend Return 39.73% 68% D+ 91% A-
Total Return 0.64% 44% F 16% F
Risk Return Profile  
Volatility (Standard Deviation) 68.19% 54% F 12% F
Risk Adjusted Return 58.27% 82% B 71% C-
Market Capitalization 0.55B N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.